Josh Hardy moves out of ICU
Josh Hardy, the 7-year-old Fredericksburg boy whose fight for access to an experimental drug drew national attention, has been moved out of the intensive care unit at St. Jude Children’s Research Hospital.
His mother, Aimee Hardy, announced on Facebook Tuesday that Josh, a four-time cancer survivor who received a bone marrow transplant in January, has been moved to the transplant floor.
The deadly adenovirus he had been battling has all but disappeared from his bloodstream after multiple doses of brincidofovir, a drug being developed by Chimerix Inc. Josh first took the drug March 12 and is now part of a new clinical trial for the drug.
His family is still praying for his kidney function, damaged by another drug, to return.